Johnson & Johnson Kick-Starts Suzhou Production
This article was originally published in PharmAsia News
Executive Summary
Johnson & Johnson Medical has commenced operation at its Suzhou Industrial Park, starting off with orthopedic implants, which have been experiencing the fastest growth in the firm's portfolio. The first DePuy factory will make products related to artificial joint replacement and trauma care to fulfill 10-20 percent of the company's global output. With other localized products coming online, the Suzhou base is set to become J&J Medical's largest production facility in the next five years. There are plans to introduce minimally invasive surgical devices by the end of this year and cardiology products in 2009. China is experiencing huge domestic demand and growth for orthopedic implants; the market is expected to increase from 500 million yuan in 2007 to 2.1 billion yuan in 2015. (Click here for more - Chinese Language)
You may also be interested in...
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.
GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health
Voluson Signature 20 and 18 ultrasound provides clinicians with workflow efficiencies in detecting female reproductive health problems, especially those related to pregnancy.